/PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. health care companies, announced today the retirement of John "Jack" Pietruski, age 76, from its Board of Directors. Mr. Pietruski's retirement is effective
May 1, 2010
"Jack has been an invaluable Board Director over the past 12 years, helping to guide the company through its IPO and its subsequent growth years, as well as during more difficult periods," said
John P. Dugan
, Chairman of the Board of Directors. "On behalf of our management team and the entire board, we would like to thank Jack for his wisdom, experience and many years of diligence and hard work as a PDI Director. I have worked closely with him for 12 years and I have grown to value Jack as a trusted advisor and colleague. His presence will be missed by me and the rest of the PDI organization."
Chief Executive Officer
stated, "Since joining PDI in
, I have personally benefited from Jack's counsel, guidance and experience as we embarked on the transformation of the company. Many of the positive new developments that we have announced during the past couple of months are a direct result of Jack's involvement, wisdom and contributions. We wish him well in his retirement."
PDI provides commercialization services for established and emerging biopharmaceutical companies. The company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales and marketing expertise. For more information, please visit the company's website at
SOURCE PDI, Inc.